US 9725431
Oligomer-tricyclic conjugates
granted A61KA61K47/60A61P
Quick answer
US patent 9725431 (Oligomer-tricyclic conjugates) held by Nektar Therapeutics expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K47/60, A61P, A61P25/02, A61P25/08